The company witnessed a 23.71% growth in the revenue at Rs. 735.99 millions for the quarter ended March 2022 as compared to Rs. 594.93 millions during the year-ago period.Profit for the quarter ended March 2022 rises by 53.30% to Rs. 118.76  millions from Rs. 77.47 millions.Operating profit surged to 234.91 millions from the corresponding previous quarter of 168.98 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 735.99 594.93 23.71 2759.80 2090.51 32.02 2759.80 2090.51 32.02
Other Income 4.19 2.38 76.05 14.54 8.10 79.51 14.54 8.10 79.51
PBIDT 234.91 168.98 39.02 812.26 535.01 51.82 812.26 535.01 51.82
Interest 5.74 6.78 -15.34 14.96 21.67 -30.96 14.96 21.67 -30.96
PBDT 229.17 162.20 41.29 785.06 513.34 52.93 785.06 513.34 52.93
Depreciation 66.44 57.87 14.81 231.58 229.37 0.96 231.58 229.37 0.96
PBT 162.73 104.33 55.98 553.48 283.97 94.91 553.48 283.97 94.91
TAX 43.97 26.86 63.70 142.90 71.37 100.22 142.90 71.37 100.22
Deferred Tax 5.40 4.80 12.50 -10.33 -4.89 111.25 -10.33 -4.89 111.25
PAT 118.76 77.47 53.30 410.58 212.60 93.12 410.58 212.60 93.12
Equity 44.22 44.22 0.00 44.22 44.22 0.00 44.22 44.22 0.00
PBIDTM(%) 31.92 28.40 12.37 29.43 25.59 15.00 29.43 25.59 15.00

Vimta Labs Share Price

481.40 17.15 (3.69%)
23-Apr-2024 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1483.75
Dr. Reddys Lab 5947.30
Cipla 1347.70
Zydus Lifesciences 958.90
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.